DuRvalumab with chEmotherapy as first line treAtment in advanced pleural Mesothelioma: A phase 3 randomised trial. The DREAM3R trial

被引：0
|
作者：
John, Thomas [1 ]
Forde, Patrick [2 ]
Kok, Peey Sei [3 ]
Brown, Chris [3 ]
Sun, Zhuoxin [4 ]
O'Byrne, Kenneth [5 ,6 ]
Yip, Sonia [3 ]
Anagnostou, Valasamo [7 ]
Cook, Alistair [8 ,9 ]
Lesterhuis, Willem J. [8 ]
Hughes, Brett G. M. [10 ,11 ]
Johnson, Lisa [12 ]
Oostendorp, Martijn [3 ]
Marinucci, Donna [12 ]
Fitzpatrick, Karen [12 ]
Ford, Kate [3 ]
Pavlakis, Nick [13 ,14 ]
Brahmer, Julie [2 ]
Stockler, Martin R. [3 ]
Ramalingam, Suresh [15 ]
Nowak, Anna [8 ,9 ,16 ]
机构：
[1] Peter MacCallum Canc Ctr, Med Oncol, Melbourne, Vic, Australia
[2] Johns Hopkins Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[3] Univ Sydney, Nhmrc Clin Trials Ctr, Camperdown, NSW, Australia
[4] IBCSG Stat Ctr, Boston, MA USA
[5] Princess Alexandra Hosp, Brisbane, Qld, Australia
[6] Queensland Univ Technol, Brisbane, Qld, Australia
[7] Johns Hopkins Univ, Bloomberg Kimmel Inst Canc Immunotherapy, Baltimore, MD USA
[8] Univ Western Australia, Natl Ctr Asbestos Related Dis, Perth, WA, Australia
[9] Univ Western Australia, Med Sch, Perth, WA, Australia
[10] Prince Charles Hosp, Canc Care Serv, Brisbane, Qld, Australia
[11] Univ Queensland, Brisbane, Qld, Australia
[12] PrECOG, Philadelphia, PA USA
[13] Northern Canc Inst, Sydney, NSW, Australia
[14] Univ Sydney, Sydney, NSW, Australia
[15] Emory Univ Hosp, Winship Canc Inst, 1364 Clifton Rd NE, Atlanta, GA 30322 USA
[16] Sir Charles Gairdner Hosp, Med Oncol, Perth, WA, Australia
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
404
引用
收藏
页码：205 / 206
页数：2
相关论文
共 50 条
  • [1] Durvalumab with chemotherapy as first line treatment in advanced pleural mesothelioma: A phase 3, randomised trial (DREAM3R).
    Forde, Patrick M.
    Nowak, Anna K.
    Hughes, Brett Gordon Maxwell
    Kok, Peey Sei
    Brown, Chris
    Sun, Zhuoxin
    Anagnostou, Valsamo
    O'Byrne, Ken
    Yip, Sonia
    Cook, Alistair
    Lesterhuis, Willem Joost
    Pavlakis, Nick
    Brahmer, Julie R.
    Kindler, Hedy L.
    Tsao, Anne S.
    Zauderer, Marjorie Glass
    Ramalingam, Suresh S.
    Stockler, Martin R.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] DREAM3R: DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma: A Phase 3 Randomised Trial
    Forde, P.
    Kindler, H.
    Zauderer, M.
    Sun, Z.
    Ramalingam, S.
    Anagnostou, V.
    Brahmer, J. R.
    Nowak, A. K.
    Kok, P. S.
    Brown, C.
    Yip, S.
    Cook, A.
    Lesterhuis, W. J.
    Hughes, B. G. M.
    Pavlakis, N.
    Stockler, M. R.
    O'Byrne, K. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 112 (02): : E9 - E10
  • [3] DREAM3R: Durvalumab With Chemotherapy as First Line Treatment in Advanced Pleural Mesothelioma - A Phase 3 Randomised Trial
    Forde, P.
    Stockler, M.
    Kok, P. S.
    Brown, C.
    Sun, Z.
    O'Byrne, K.
    Yip, S.
    Anagnostou, V.
    Cook, A.
    Lesterhuis, W. J.
    Hughes, B.
    Kindler, H.
    Tsao, A.
    Zauderer, M.
    Bricker, A.
    Oostendorp, M.
    Marinucci, D.
    Fitzpatrick, K.
    Ford, K.
    Pavlakis, N.
    Brahmer, J.
    Ramalingam, S.
    Nowak, A.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S957 - S957
  • [4] Protocol of DREAM3R: DuRvalumab with chEmotherapy as first-line treAtment in advanced pleural Mesothelioma - a phase 3 randomised trial
    Kok, Peey Sei
    Forde, Patrick M.
    Hughes, Brett
    Sun, Zhuoxin
    Brown, Chris
    Ramalingam, Suresh
    Cook, Alistair
    Lesterhuis, Willem Joost
    Yip, Sonia
    O'Byrne, Ken
    Pavlakis, Nick
    Brahmer, Julie
    Anagnostou, Valsamo
    Ford, Kate
    Fitzpatrick, Karen
    Bricker, Alison
    Cummins, Michelle M.
    Stockler, Martin
    Nowak, Anna K.
    BMJ OPEN, 2022, 12 (01):
  • [5] DREAM3R: Durvalumab with chemotherapy as first-line treatment in advanced pleural mesothelioma-A phase 3 randomized trial.
    Forde, Patrick M.
    Nowak, Anna K.
    Kok, Peey-Sei
    Brown, Chris
    Sun, Zhuoxin
    Anagnostou, Valsamo
    O'Byrne, Kenneth John
    Yip, Sonia
    Cook, Alistair
    Lesterhuis, Willem Joost
    Hughes, Brett Gordon Maxwell
    Pavlakis, Nick
    Brahmer, Julie R.
    Kindler, Hedy L.
    Tsao, Anne S.
    Zauderer, Marjorie Glass
    Ramalingam, Suresh S.
    Stockler, Martin R.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [6] DREAM3R: Durvalumab with chemotherapy as firstline treatment in advanced pleural mesothelioma-A phase 3 randomized trial.
    Forde, Patrick M.
    Nowak, Anna K.
    Kok, Peey-Sei
    Brown, Chris
    Sun, Zhuoxin
    Anagnostou, Valsamo
    O'Byrne, Kenneth John
    Yip, Sonia
    Cook, Alistair
    Lesterhuis, Willem Joost
    Hughes, Brett Gordon Maxwell
    Pavlakis, Nick
    Brahmer, Julie R.
    Tsao, Hedy L. Kindler Anne S.
    Zauderer, Marjorie Glass
    Ramalingam, Suresh S.
    Stockler, Martin R.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [7] DREAM - A Phase 2 Trial of DuRvalumab with First Line chEmotherApy in Mesothelioma with a Safety Run In
    Nowak, Anna
    Kok, Peey-Sei
    Livingstone, Ann
    Lesterhuis, Willem Joost
    Yip, Sonia
    Donoghoe, Mark
    Lam, Wei-Sen
    Stockler, Martin
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1086 - S1087
  • [8] DREAM - A Phase 2 Trial of Durvalumab with First Line Chemotherapy in Mesothelioma: Final Result
    Nowak, A.
    Kok, P.
    Lesterhuis, W.
    Hughes, B.
    Brown, C.
    Kao, S.
    Karikios, D.
    John, T.
    Pavlakis, N.
    O'Byrne, K.
    Yip, S.
    Lam, W.
    Briscoe, K.
    Karapetis, C.
    Stockler, M.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S338 - S339
  • [9] DREAM - a phase 2 trial of DuRvalumab with first line chEmotherApy in mesothelioma: final result
    Kok, Peey-Sei
    Stockler, Martin
    Lesterhuis, Willem
    Hughes, Brett
    Brown, Chris
    Kao, Steven Chuan-Hao
    Karikios, Deme
    John, Thomas
    Pavlakis, Nick
    O'Byrne, Keno
    Yip, Sonia
    Lam, Wei-Sen
    Briscoe, Karen
    Karapetis, Chris
    Nowak, Anna
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 83 - 84
  • [10] Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-in
    Nowak, Anna K.
    Lesterhuis, W. Joost
    Kok, Peey-Sei
    Brown, Chris
    Hughes, Brett G. M.
    Karikios, Deme J.
    John, Thomas
    Kao, Steven C-H
    Leslie, Connull
    Cook, Alistair M.
    Pavlakis, Nick
    Briscoe, Karen
    O'Byrne, Kenneth J.
    Karapetis, Christos S.
    Lam, Wei-Sen
    Langford, Ailsa
    Yip, Sonia
    Stockler, Martin R.
    LANCET ONCOLOGY, 2020, 21 (09): : 1213 - 1223
12345